SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-001850
Filing Date
2021-04-02
Accepted
2021-04-02 21:02:12
Documents
2
Period of Report
2021-04-01

Document Format Files

Seq Description Document Type Size
1 form3-04022021_060401.html 3  
1 form3-04022021_060401.xml 3 1695
2 ex24-04022021_060401.htm EX-24 6847
  Complete submission text file 0001415889-21-001850.txt   10261
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address DAMONMILL SQUARE SUITE 6A CONCORD MA 01742
Business Address
Geffken Daniel E. (Reporting) CIK: 0001314756 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31326 | Film No.: 21803577